Agilent Technologies, Inc. · NYSE:A
Agilent Technologies — Merger or Acquisition (May 2012)
6 slides from Agilent Technologies's merger presentation, May 17, 2012
Slide 1: Agilent to Acquire Dako Investor Presentation
AGILENT TO ACQUIRE DAKO INVESTOR PRESENTATION M AY 1 7 , 2 0 1 2
Slide 2: Safe Harbor
SAFE HARBOR This presentation contains forward-looking statements (including, without limitation, information and future guidance on our goals, priorities, revenues, demand, growth opportunities, customer service and innovation plans, new product introductions, financial condition, earnings, the con
Slide 3: Dako Overview
D A KO O V E R V I E W • Founded in 1966 with headquarters in Denmark, Dako employs over 1,000 people worldwide, primarily in Denmark; Carpinteria, California; and other parts of the world • Dako is a leader within cancer diagnostics in Anatomic Pathology • Pathology represents ~85% of Dako's revenu
Slide 4: Strategic Rationale for Transaction
S T R AT E G I C R AT I O N A L E F O R T R A N S A C T I O N • Builds a solid foundation in two high growth diagnostics markets • Anatomic Pathology - $2.2B growing 8-10%* • Molecular Diagnostics - $4.5B growing 10-15%* • Adds channel and regulatory capability • Strategically complements Agilent’s
Slide 5: Transaction Overview and Financial Impact
T R A N S A C T I O N O V E R V I E W A N D F I N A N C I A L I M PA C T • $2.2B purchase price, all-cash transaction • Currently owned by European private equity firm, EQT Transaction Partners Terms • Expected to close within the next 60 days, subject to customary closing conditions and regulatory
Slide 6: Complementary Merger
C O M P L E M E N TA R Y M E R G E R Merger of Complementary • Global leader in • Global leader in Strengths instrumentation for anatomic pathology bio-analytical reagents • Accelerates Agilent’s measurement • Long-time, trusted penetration in Life supplier of clinical labs Sciences and • Portfolio
Agilent Technologies — Merger or Acquisition (May 2012) on 6ix